annual CFF:
-$486.70M-$552.00M(-845.33%)Summary
- As of today (May 29, 2025), NBIX annual cash flow from financing activities is -$486.70 million, with the most recent change of -$552.00 million (-845.33%) on December 31, 2024.
- During the last 3 years, NBIX annual CFF has fallen by -$514.10 million (-1876.28%).
- NBIX annual CFF is now -194.20% below its all-time high of $516.65 million, reached on December 31, 2017.
Performance
NBIX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$117.90M+$172.10M(+59.34%)Summary
- As of today (May 29, 2025), NBIX quarterly cash flow from financing activities is -$117.90 million, with the most recent change of +$172.10 million (+59.34%) on March 31, 2025.
- Over the past year, NBIX quarterly CFF has dropped by -$187.80 million (-268.67%).
- NBIX quarterly CFF is now -123.28% below its all-time high of $506.49 million, reached on June 30, 2017.
Performance
NBIX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$674.50M-$187.80M(-38.59%)Summary
- As of today (May 29, 2025), NBIX TTM cash flow from financing activities is -$674.50 million, with the most recent change of -$187.80 million (-38.59%) on March 31, 2025.
- Over the past year, NBIX TTM CFF has dropped by -$801.50 million (-631.10%).
- NBIX TTM CFF is now -226.96% below its all-time high of $531.25 million, reached on March 31, 2018.
Performance
NBIX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NBIX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -845.3% | -268.7% | -631.1% |
| 3 y3 years | -1876.3% | -2032.8% | -3765.8% |
| 5 y5 years | -1602.2% | -2065.0% | -1984.1% |
NBIX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -845.3% | at low | -268.7% | +59.8% | -631.1% | at low |
| 5 y | 5-year | -845.3% | at low | -268.7% | +59.8% | -631.1% | at low |
| alltime | all time | -194.2% | at low | -123.3% | +59.8% | -227.0% | at low |
NBIX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$117.90M(-59.3%) | -$674.50M(+38.6%) |
| Dec 2024 | -$486.70M(-845.3%) | -$290.00M(-1198.5%) | -$486.70M(+201.7%) |
| Sep 2024 | - | $26.40M(-109.0%) | -$161.30M(-4.5%) |
| Jun 2024 | - | -$293.00M(-519.2%) | -$168.90M(-233.0%) |
| Mar 2024 | - | $69.90M(+97.5%) | $127.00M(+94.5%) |
| Dec 2023 | $65.30M(-127.9%) | $35.40M(+88.3%) | $65.30M(+19.8%) |
| Sep 2023 | - | $18.80M(+548.3%) | $54.50M(+15.7%) |
| Jun 2023 | - | $2.90M(-64.6%) | $47.10M(-120.3%) |
| Mar 2023 | - | $8.20M(-66.7%) | -$232.20M(-0.9%) |
| Dec 2022 | -$234.30M(-955.1%) | $24.60M(+115.8%) | -$234.30M(-8.9%) |
| Sep 2022 | - | $11.40M(-104.1%) | -$257.10M(-1.5%) |
| Jun 2022 | - | -$276.40M(-4631.1%) | -$261.00M(-1518.5%) |
| Mar 2022 | - | $6.10M(+238.9%) | $18.40M(-32.8%) |
| Dec 2021 | $27.40M(-117.4%) | $1.80M(-76.0%) | $27.40M(-117.2%) |
| Sep 2021 | - | $7.50M(+150.0%) | -$159.40M(-1.3%) |
| Jun 2021 | - | $3.00M(-80.1%) | -$161.50M(+8.6%) |
| Mar 2021 | - | $15.10M(-108.2%) | -$148.70M(-5.8%) |
| Dec 2020 | -$157.80M(-587.0%) | -$185.00M(-3525.9%) | -$157.80M(-498.5%) |
| Sep 2020 | - | $5.40M(-65.8%) | $39.60M(-16.3%) |
| Jun 2020 | - | $15.80M(+163.3%) | $47.30M(+32.1%) |
| Mar 2020 | - | $6.00M(-51.6%) | $35.80M(+10.5%) |
| Dec 2019 | $32.40M(+9.8%) | $12.40M(-5.3%) | $32.40M(+49.0%) |
| Sep 2019 | - | $13.10M(+204.7%) | $21.75M(+53.8%) |
| Jun 2019 | - | $4.30M(+65.4%) | $14.14M(-11.4%) |
| Mar 2019 | - | $2.60M(+48.4%) | $15.96M(-45.9%) |
| Dec 2018 | $29.50M(-94.3%) | $1.75M(-68.1%) | $29.50M(-11.5%) |
| Sep 2018 | - | $5.49M(-10.3%) | $33.35M(+8.0%) |
| Jun 2018 | - | $6.12M(-62.1%) | $30.88M(-94.2%) |
| Mar 2018 | - | $16.14M(+188.1%) | $531.25M(+2.8%) |
| Dec 2017 | $516.65M(>+9900.0%) | $5.60M(+85.3%) | $516.65M(+1.1%) |
| Sep 2017 | - | $3.02M(-99.4%) | $511.11M(+0.3%) |
| Jun 2017 | - | $506.49M(>+9900.0%) | $509.42M(>+9900.0%) |
| Mar 2017 | - | $1.53M(+2330.2%) | $3.86M(+61.5%) |
| Dec 2016 | $2.39M(-99.1%) | $63.00K(-95.3%) | $2.39M(-27.5%) |
| Sep 2016 | - | $1.33M(+42.0%) | $3.29M(+21.8%) |
| Jun 2016 | - | $936.00K(+1409.7%) | $2.71M(-23.3%) |
| Mar 2016 | - | $62.00K(-93.6%) | $3.53M(-98.7%) |
| Dec 2015 | $276.99M(+99.7%) | $968.00K(+30.8%) | $276.99M(-0.3%) |
| Sep 2015 | - | $740.00K(-57.9%) | $277.76M(+0.1%) |
| Jun 2015 | - | $1.76M(-99.4%) | $277.50M(+0.5%) |
| Mar 2015 | - | $273.52M(>+9900.0%) | $276.01M(+99.0%) |
| Dec 2014 | $138.73M(+2516.6%) | $1.73M(+257.9%) | $138.73M(+1.2%) |
| Sep 2014 | - | $484.00K(+76.6%) | $137.05M(-1.6%) |
| Jun 2014 | - | $274.00K(-99.8%) | $139.23M(-1.0%) |
| Mar 2014 | - | $136.24M(>+9900.0%) | $140.58M(+2551.4%) |
| Dec 2013 | $5.30M(-93.7%) | $50.00K(-98.1%) | $5.30M(-4.3%) |
| Sep 2013 | - | $2.66M(+63.8%) | $5.54M(+84.9%) |
| Jun 2013 | - | $1.63M(+68.2%) | $3.00M(+111.8%) |
| Mar 2013 | - | $966.00K(+235.4%) | $1.42M(-98.3%) |
| Dec 2012 | $83.70M(>+9900.0%) | $288.00K(+144.1%) | $83.70M(+0.3%) |
| Sep 2012 | - | $118.00K(+174.4%) | $83.44M(+0.1%) |
| Jun 2012 | - | $43.00K(-99.9%) | $83.36M(-0.1%) |
| Mar 2012 | - | $83.25M(>+9900.0%) | $83.48M(>+9900.0%) |
| Dec 2011 | $286.00K(-98.7%) | $22.00K(-51.1%) | $286.00K(-21.2%) |
| Sep 2011 | - | $45.00K(-72.2%) | $363.00K(+6.8%) |
| Jun 2011 | - | $162.00K(+184.2%) | $340.00K(+87.8%) |
| Mar 2011 | - | $57.00K(-42.4%) | $181.00K(-99.2%) |
| Dec 2010 | $21.48M | $99.00K(+350.0%) | $21.48M(-31.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $22.00K(+633.3%) | $31.28M(+0.1%) |
| Jun 2010 | - | $3000.00(-100.0%) | $31.26M(+0.0%) |
| Mar 2010 | - | $21.36M(+115.7%) | $31.26M(+215.7%) |
| Dec 2009 | $9.90M(-781.8%) | $9.90M(>+9900.0%) | $9.90M(-3700.0%) |
| Sep 2009 | - | $0.00(0.0%) | -$275.00K(-54.2%) |
| Jun 2009 | - | $0.00(0.0%) | -$600.00K(-39.5%) |
| Mar 2009 | - | $0.00(-100.0%) | -$991.00K(-31.7%) |
| Dec 2008 | -$1.45M(-102.5%) | -$275.00K(-15.4%) | -$1.45M(-102.5%) |
| Sep 2008 | - | -$325.00K(-16.9%) | $58.94M(+1.3%) |
| Jun 2008 | - | -$391.00K(-15.2%) | $58.19M(+0.5%) |
| Mar 2008 | - | -$461.00K(-100.8%) | $57.88M(+1.2%) |
| Dec 2007 | $57.18M(+466.9%) | $60.12M(-5702.8%) | $57.18M(-1500.8%) |
| Sep 2007 | - | -$1.07M(+53.5%) | -$4.08M(-7.7%) |
| Jun 2007 | - | -$699.00K(-40.0%) | -$4.42M(+25.1%) |
| Mar 2007 | - | -$1.17M(+1.7%) | -$3.54M(-135.0%) |
| Dec 2006 | $10.09M(-2.4%) | -$1.15M(-19.1%) | $10.09M(-45.5%) |
| Sep 2006 | - | -$1.42M(-844.7%) | $18.50M(-22.7%) |
| Jun 2006 | - | $190.00K(-98.5%) | $23.92M(+0.9%) |
| Mar 2006 | - | $12.46M(+71.3%) | $23.71M(+129.5%) |
| Dec 2005 | $10.33M(-71.8%) | $7.27M(+81.6%) | $10.33M(+344.8%) |
| Sep 2005 | - | $4.00M(<-9900.0%) | $2.32M(-75.5%) |
| Jun 2005 | - | -$19.00K(-97.9%) | $9.49M(-59.3%) |
| Mar 2005 | - | -$922.00K(+24.6%) | $23.30M(-36.5%) |
| Dec 2004 | $36.69M(-82.6%) | -$740.00K(-106.6%) | $36.69M(-29.7%) |
| Sep 2004 | - | $11.17M(-19.0%) | $52.22M(-77.3%) |
| Jun 2004 | - | $13.79M(+10.5%) | $230.16M(+5.0%) |
| Mar 2004 | - | $12.47M(-15.6%) | $219.12M(+3.8%) |
| Dec 2003 | $211.06M(+3532.1%) | $14.79M(-92.2%) | $211.06M(+6.0%) |
| Sep 2003 | - | $189.11M(+6786.8%) | $199.03M(+1605.3%) |
| Jun 2003 | - | $2.75M(-37.8%) | $11.67M(+13.8%) |
| Mar 2003 | - | $4.41M(+60.2%) | $10.25M(+76.4%) |
| Dec 2002 | $5.81M(-96.8%) | $2.75M(+56.9%) | $5.81M(-96.8%) |
| Sep 2002 | - | $1.76M(+32.3%) | $182.06M(+1.1%) |
| Jun 2002 | - | $1.33M(-5014.8%) | $180.17M(-0.4%) |
| Mar 2002 | - | -$27.00K(-100.0%) | $180.88M(-0.2%) |
| Dec 2001 | $181.30M(+92.6%) | $179.01M(<-9900.0%) | $181.30M(+93.6%) |
| Sep 2001 | - | -$140.00K(-106.8%) | $93.65M(-1.7%) |
| Jun 2001 | - | $2.05M(+423.3%) | $95.23M(+2.1%) |
| Mar 2001 | - | $391.00K(-99.6%) | $93.30M(-0.9%) |
| Dec 2000 | $94.13M(+129.6%) | $91.36M(+6275.2%) | $94.13M(+117.0%) |
| Sep 2000 | - | $1.43M(+1114.4%) | $43.38M(+2.9%) |
| Jun 2000 | - | $118.00K(-90.4%) | $42.14M(-0.4%) |
| Mar 2000 | - | $1.22M(-97.0%) | $42.32M(+3.2%) |
| Dec 1999 | $41.00M(+2057.9%) | $40.60M(>+9900.0%) | $41.00M(>+9900.0%) |
| Sep 1999 | - | $200.00K(-33.3%) | $300.00K(-88.0%) |
| Jun 1999 | - | $300.00K(-400.0%) | $2.50M(+31.6%) |
| Mar 1999 | - | -$100.00K(0.0%) | $1.90M(0.0%) |
| Dec 1998 | $1.90M(+171.4%) | -$100.00K(-104.2%) | $1.90M(-32.1%) |
| Sep 1998 | - | $2.40M(-900.0%) | $2.80M(+833.3%) |
| Jun 1998 | - | -$300.00K(+200.0%) | $300.00K(-40.0%) |
| Mar 1998 | - | -$100.00K(-112.5%) | $500.00K(-28.6%) |
| Dec 1997 | $700.00K(-98.5%) | $800.00K(-900.0%) | $700.00K(-333.3%) |
| Sep 1997 | - | -$100.00K(0.0%) | -$300.00K(-25.0%) |
| Jun 1997 | - | -$100.00K(-200.0%) | -$400.00K(-101.0%) |
| Mar 1997 | - | $100.00K(-150.0%) | $42.10M(-10.0%) |
| Dec 1996 | $46.80M | -$200.00K(0.0%) | $46.80M(-0.4%) |
| Sep 1996 | - | -$200.00K(-100.5%) | $47.00M(-0.4%) |
| Jun 1996 | - | $42.40M(+783.3%) | $47.20M(+883.3%) |
| Mar 1996 | - | $4.80M | $4.80M |
FAQ
- What is Neurocrine Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual CFF year-on-year change?
- What is Neurocrine Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly CFF year-on-year change?
- What is Neurocrine Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM CFF year-on-year change?
What is Neurocrine Biosciences annual cash flow from financing activities?
The current annual CFF of NBIX is -$486.70M
What is the all time high annual CFF for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual cash flow from financing activities is $516.65M
What is Neurocrine Biosciences annual CFF year-on-year change?
Over the past year, NBIX annual cash flow from financing activities has changed by -$552.00M (-845.33%)
What is Neurocrine Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of NBIX is -$117.90M
What is the all time high quarterly CFF for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly cash flow from financing activities is $506.49M
What is Neurocrine Biosciences quarterly CFF year-on-year change?
Over the past year, NBIX quarterly cash flow from financing activities has changed by -$187.80M (-268.67%)
What is Neurocrine Biosciences TTM cash flow from financing activities?
The current TTM CFF of NBIX is -$674.50M
What is the all time high TTM CFF for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM cash flow from financing activities is $531.25M
What is Neurocrine Biosciences TTM CFF year-on-year change?
Over the past year, NBIX TTM cash flow from financing activities has changed by -$801.50M (-631.10%)